n-Hexane
n-Hexane releases at Eunice Gas Plant fell from 68k lb to 2k lb (97% lower) between 2023 and 2024.
TRI facility · TRI 2024 reporting year
Eunice Gas Plant
Total reported releases 12.2M lb held roughly steady year over year (-1%). Total releases concentrations are roughly unchanged from 2023.
25 MIDDLE PLANT LN, Eunice, New Mexico · 211130 · Natural Gas Processing · operated by Targa Resources CORP
Anomaly engine
Notable Signals
Cyclohexane
Cyclohexane releases at Eunice Gas Plant fell from 30k lb to 7k lb (78% lower) between 2023 and 2024.
Chemicals reported · most recent year
What This Facility Releases
Hydrogen sulfide
Hydrogen sulfide concentrations are roughly unchanged from 2023.
Benzene
Benzene concentrations have fallen 22% since 2022.
Toluene
Toluene concentrations have fallen 34% since 2022.
Xylene (mixed isomers)
Xylene (mixed isomers) concentrations are up 81% since 2022.
Ethylbenzene
Ethylbenzene concentrations are roughly unchanged from 2023.
Cyclohexane
Cyclohexane concentrations have more than halved since 2022.
n-Hexane
n-Hexane concentrations have more than halved since 2022.
Equity context · ACS 2018-2022 block-group demographics
Who Lives Next To This Facility
Within 3 miles of this facility (3 Census block groups, population-weighted demographics): a population of 2,497. Why we surface this →
38.6%
Low-income
51.6%
People of color
3.9%
Under age 5
16.2%
Over age 64
Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.
Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.
What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.